Loading…
Seer, Inc. is projected to rise to $2.48 by 2027, a +14% move from its current price of $2.17. SEER is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/12/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $2.12 | $2.17 | $2.22 | +0.07% |
| Jul 14 | $2.10 | $2.17 | $2.25 | +0.15% |
| Jul 15 | $2.09 | $2.17 | $2.26 | +0.22% |
| Jul 16 | $2.08 | $2.18 | $2.28 | +0.29% |
| Jul 17 | $2.07 | $2.18 | $2.29 | +0.37% |
| Jul 18 | $2.06 | $2.18 | $2.31 | +0.44% |
| Jul 19 | $2.05 | $2.18 | $2.32 | +0.52% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $2.05 | $2.18 | $2.32 | +0.52% |
| Week 2 | $2.01 | $2.19 | $2.39 | +1.03% |
| Week 3 | $1.98 | $2.20 | $2.45 | +1.55% |
| Week 4 | $1.96 | $2.22 | $2.50 | +2.08% |
| Week 5 | $1.94 | $2.23 | $2.55 | +2.60% |
| Week 6 | $1.93 | $2.24 | $2.60 | +3.13% |
| Week 7 | $1.91 | $2.25 | $2.64 | +3.66% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Seer, Inc. is a life sciences company that develops and commercializes products to decode the biology of the proteome to improve human health in the United States, China, Australia, Europe, Israel, Japan, and South Africa. The company offers Proteograph Product Suite, an integrated solution, which includes proprietary engineered nanoparticles, consumables, automation instrumentation, and data analysis software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only.
It markets and sells its products for research use only, which cover academic institutions, life sciences, and research laboratories as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. The company also offers Proteograph ONE, a third-generation assay; Proteograph DIRECT, which provides an automated approach for direct digestion of samples for bottom-up LC-MS proteomic analysis; and Proteograph Analysis Suite, a data analytics software suite designed to support quality control, data management, and interpretation of Proteograph output which is currently offered as a cloud-based solution.
The company was formerly known as Seer Biosciences, Inc. and changed its name to Seer, Inc. in July 2018. Seer, Inc. was incorporated in 2017 and is headquartered in Redwood City, California.
Seer, Inc. (SEER) is a healthcare company with a current price of $2.19 and a market capitalization of $120.41M. It is ranked 4064 by market cap. The stock sits at a price level that the forecast projects as the starting point for a multi-year rise, with the 2026 average price at $2.19 and a path that reaches higher levels over the coming years.
The long-term forecast shows the average price progressing from $2.19 in 2026 to higher levels, with the 2030 average at $3.12 and the 2050 average at $14.10, alongside substantial upside in max values and ROI figures. These projections imply meaningful upside potential relative to the current level, albeit with inherent uncertainty and variability year to year.
A major floor 35.3% below — a decisive break under it would weaken the trend.
The nearest floor, 25.3% below — buyers have tended to step in here.
Price is pressing into resistance (2.3% away) — a breakout level to watch.
A major ceiling 20.0% above — clearing it would confirm fresh momentum.
Key SEER support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of SEER market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $2.19 | Sell | $2.12 | Buy |
| MA 10 | $1.92 | Buy | $2.00 | Buy |
| MA 20 | $1.82 | Buy | $1.90 | Buy |
| MA 50 | $1.82 | Buy | $1.84 | Buy |
| MA 100 | $1.83 | Buy | $1.85 | Buy |
| MA 200 | $1.92 | Buy | $1.90 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 70.68 | Sell |
| Stoch RSI (14) | 86.50 | Sell |
| CCI (20) | 125.45 | Buy |
| Williams %R (14) | -8.33 | Info |
| MACD (12,26,9) | 0.06 | Buy |
| ROC (12) | 25.43 | Buy |
| Bollinger %B (20,2) | 0.90 | Neutral |
| Stochastic %K (14) | 91.67 | Sell |
| TRIX (15) | 0.21 | Buy |
| Awesome (5,34) | 0.37 | Buy |
| Ultimate (7,14,28) | 78.35 | Sell |
| Momentum (10) | 0.44 | Buy |
| Aroon Osc (25) | 8.00 | Buy |
| Hull MA (9) | 2.34 | Sell |
| ADX (14) | 28.32 | Buy |
| ATR (14) | 0.06 | Info |
Near term, sentiment is neutral even as momentum remains elevated, with RSI14 at 80. The price is trading above both the SMA50 ($1.80) and the SMA200 ($1.92), suggesting constructive underpinnings but with an overbought nuance.
The current price of $2.19 sits at the indicated resistance level of $2.19, within a 30-day range of $1.85 to $2.59. A support level is noted at $1.62, providing a potential floor if downside pressure extends. The balance of indicators points to a poised short-term setup, but with caution warranted given the high RSI and nearby resistance.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $1.62 | $2.17 | $3.07 | 0% | Neutral | |
| $2.00 | $2.48 | $3.23 | +14% | Neutral | |
| $2.19 | $2.78 | $3.74 | +28% | Bullish | |
| $2.37 | $3.07 | $4.23 | +41% | Bullish | |
| $2.52 | $3.31 | $4.67 | +53% | Bullish | |
| $3.11 | $4.15 | $5.96 | +91% | Bullish | |
| $3.40 | $4.61 | $6.72 | +112% | Bullish | |
| $3.59 | $4.92 | $7.29 | +127% | Bullish | |
| $3.89 | $5.40 | $8.11 | +149% | Bullish | |
| $3.80 | $5.34 | $8.13 | +146% | Bullish | |
| $5.77 | $8.56 | $13.76 | +294% | Bullish | |
| $9.91 | $16.12 | $28.08 | +643% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $1.62 | $2.17 | $2.63 | +0.00% |
| August 2026 | $1.96 | $2.30 | $2.77 | +6.14% |
| September 2026 | $1.96 | $2.32 | $2.82 | +0.74% |
| October 2026 | $1.97 | $2.34 | $2.87 | +1.01% |
| November 2026 | $2.04 | $2.43 | $3.00 | +3.88% |
| December 2026 | $2.07 | $2.48 | $3.07 | +1.74% |
Click any year to see its month-by-month SEER forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Seer, Inc.'s 2026 outlook centres on $2.17, within a $1.62 to $3.07 range. That marks a 0% change versus current levels. Price action looks broadly range-bound.
By 2027, SEER could reach as high as $3.23, with a base case around $2.48 and support toward $2.00 — roughly +14% from $2.17. A consolidation phase looks the most probable path here.
Expect SEER to range from $2.19 to $3.74 through 2028. The $2.78 average target implies a +28% move from current prices. That is up +12% on the projected 2027 average. Momentum favours further upside here.
The SEER price prediction for 2029 points to an average of $3.07 (low $2.37, high $4.23) — a potential gain of +41% on today's $2.17. Buyers look set to stay in control over this stretch.
In 2030, SEER is projected to trade between $2.52 and $4.67, averaging $3.31 — a potential gain of +53% from today's $2.17. That is up +8% on the projected 2029 average. Momentum favours further upside here.
Seer, Inc.'s 2031 outlook centres on $4.15, within a $3.11 to $5.96 range. That is up +25% on the projected 2030 average. That marks a +91% change versus current levels. Buyers look set to stay in control over this stretch.
By 2032, SEER could reach as high as $6.72, with a base case around $4.61 and support toward $3.40 — roughly +112% from $2.17. Momentum favours further upside here.
Expect SEER to range from $3.59 to $7.29 through 2033. The $4.92 average target implies a +127% move from current prices. That is up +7% on the projected 2032 average. Buyers look set to stay in control over this stretch.
The SEER price prediction for 2034 points to an average of $5.40 (low $3.89, high $8.11) — a potential gain of +149% on today's $2.17. Momentum favours further upside here.
In 2035, SEER is projected to trade between $3.80 and $8.13, averaging $5.34 — a potential gain of +146% from today's $2.17. That is -1% versus the projected 2034 average. Buyers look set to stay in control over this stretch.
Seer, Inc.'s 2040 outlook centres on $8.56, within a $5.77 to $13.76 range. That is up +60% on the projected 2035 average. That marks a +294% change versus current levels. Momentum favours further upside here.
By 2050, SEER could reach as high as $28.08, with a base case around $16.12 and support toward $9.91 — roughly +643% from $2.17. Buyers look set to stay in control over this stretch.
Investing $1,000 in SEER today (≈ 460.829493 SEER) could be worth
$7,426.78
+$6,426.78 (+643%) by 2050 · US Dollar
Based on the average projected SEER price of $16.12 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in SEERwould be worth at today's price.
$1,000 invested in SEER on Jul 10, 2025 (≈ 456.620993 SEER) would be worth
$990.87
-$9.13 (-0.9%) today · 0.99× · US Dollar
Based on a SEER entry price of $2.19 vs. today's $2.17.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $1.62 | $1,339.51 | +34.0% |
| 1 month ago | $1.69 | $1,284.02 | +28.4% |
| 3 months ago | $1.69 | $1,284.02 | +28.4% |
| 6 months ago | $1.95 | $1,112.82 | +11.3% |
| 1 year ago | $2.19 | $990.87 | -0.9% |
| All time (5.0y) ago | $31.39 | $69.13 | -93.1% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our SEER forecast.
Our base-case forecast reaches $4.30 around 2032.
Implied market cap at $4.30: $236.42M
The multi-year forecast depicts a bullish trajectory beginning in 2027 and accelerating toward 2030 and beyond. In 2030 the average price is $3.12 with a max of $4.47 and a min of $2.34, yielding a forecast ROI of 42.4 and a bullish sentiment. By 2040 the average price rises to $7.79, with a max of $12.87 and a min of $5.10, offering a forecast ROI of 255.6 and a bullish stance.
By 2050 the average price is projected at $14.10, with a max of $25.40 and a min of $8.32, equating to a forecast ROI of 544 and a bullish outlook. The forecast through these years indicates substantial upside from current levels, but it remains subject to the usual uncertainties and market dynamics that affect equities and speculative assets.
Overall, the long-term outlook shows meaningful upside with higher average prices and higher ROI in later years, supported by a bullish sentiment in the longer horizon, while acknowledging that these are estimates and not guarantees.
Tap a question to reveal the answer.
Average price $3.12, with a min of $2.34 and a max of $4.47. ROI 42.4, sentiment BULLISH.
The forecast shows a path from $2.19 in 2026 to higher averages by 2030, 2040, and 2050, with ROI as high as 42.4 (2030), 255.6 (2040), and 544 (2050). These are estimates and not guarantees.
Yes, the max price in 2040 is $12.87 and in 2050 is $25.40, with the 2050 max $25.40 and 544 ROI, indicating substantial upside potential according to the forecast.
Current price $2.19. Market capitalization $120.41M.
RSI14 is 80 with neutral sentiment. The stock trades above SMA50 ($1.80) and SMA200 ($1.92), with a 30-day range of $1.85 to $2.59 and a resistance level at $2.19 and a support level at $1.62.
Seer, Inc. Community Discussion
0Share your Seer, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.